BiotechTube
Clear Labs

Clear Labs

San Carlos, United States· Est. 2014

Clear Labs is on a mission to liberate genomics by automating complex NGS workflows, translating vast genomic data into actionable insights. The company has established a strong market presence with over 100 systems deployed globally and has secured significant Series D funding to accelerate development. Its strategic focus includes expanding from infectious disease and food safety into oncology research through key collaborations and platform enhancements.

clearlabs.com

Private Company

Total funding raised: $33.5M

AI Company Overview

Clear Labs is on a mission to liberate genomics by automating complex NGS workflows, translating vast genomic data into actionable insights. The company has established a strong market presence with over 100 systems deployed globally and has secured significant Series D funding to accelerate development. Its strategic focus includes expanding from infectious disease and food safety into oncology research through key collaborations and platform enhancements.

OncologyInfectious Disease

Technology Platform

Fully automated, end-to-end next-generation sequencing (NGS) platforms that integrate sample preparation, sequencing, and bioinformatics into a single, walkaway workflow for research applications.

Funding History

3
Total raised:$33.5M
Series B$18MJan 15, 2018
Series A$13MOct 15, 2015
Seed$2.5MAug 15, 2014

Opportunities

Significant growth opportunities exist in expanding the installed base of automated NGS systems in oncology research labs and public health agencies.
Further integration of novel assay chemistries and AI-driven bioinformatics can deepen platform utility.
Strategic partnerships with large diagnostic service providers offer a channel for rapid market penetration.

Risk Factors

Key risks include intense competition from well-capitalized sequencing incumbents, the long sales cycles and high capital cost for laboratory equipment, and the complexity of maintaining integrated platforms that rely on third-party components and chemistries.
Any delay in product development or failure to secure additional partnerships could slow growth.

Competitive Landscape

Clear Labs competes with large integrated NGS providers like Illumina and Thermo Fisher, as well as laboratory automation specialists. Its main differentiation is offering a truly walkaway, end-to-end automated NGS workflow specifically configured for clinical research applications, reducing complexity and labor for the user compared to assembling best-in-class components separately.